Anomaly, a New York-based AI-powered payer intelligence company, has raised $17M in additional Series A funding led by Sound Ventures. The platform analyzes billions of medical claims and encounters in real-time to predict claim denials and uncover revenue risks. The capital will expand the Smart Response platform into managed care operations and payer negotiations.
AI RCM Funding Heats Up
The raise brings Anomaly's total funding to $34M and coincides with surging investor interest in AI revenue cycle management. AKASA has secured over $200M, while Infinx raised $194M. Clarify Health commands more than $400M in funding for broader analytics. Anomaly's focus on decoding payer logic differentiates it in this crowded field.
Denials Drain $18B Annually
Healthcare providers face rising claim denial rates of 15-20%, contributing to $18B in annually overturned denials and broader RCM inefficiencies. Payers increasingly deploy AI to reduce payments, creating an intelligence asymmetry that leaves providers reactive. No human team can track evolving payer tactics at scale across billions of claims. Anomaly's platform addresses this by surfacing hidden patterns before they impact revenue.
Smart Response Decodes Payer Tactics
Anomaly's Smart Response uses federated AI to analyze 3B+ medical claims and $45B in billable encounters with 97% accuracy. It predicts denials, optimizes reimbursements, and empowers negotiations by revealing payer behaviors. Unlike broader RCM automation from AKASA or prior auth focus from Infinx, Anomaly specializes in post-claims payer intelligence and anomaly detection.
The federated model preserves data privacy while leveraging network effects across customers.
As CEO Mike Desjadon noted:
"Providers have known intuitively for years that the system is rigged against them… No human team can track that at scale."
Sound Ventures Leads Expansion Round
Sound Ventures led the round with participation from Alumni Ventures and existing backers Redesign Health, RRE Ventures, and others. This growth capital signals conviction in Anomaly's traction, with deployments across 20+ health systems averaging $4B in annual net patient revenue. Investors back the shift from revenue cycle to strategic payer engagement.
RCM Market Balloons to $626B
The global healthcare RCM market stands at $225.7B in 2026, projected to reach $625.4B by 2035 at 12.05% CAGR per Precedence Research. US RCM hits $73B in 2026 with 11.6% CAGR. 76% of RCM leaders prioritize AI automation amid denial surges, per FinThrive.
Promotions Signal Team Depth
Anomaly recently promoted Mina Egan to COO, Kate Marcot to Chief Growth Officer, and Anna Roberto to Head of Sales—all internal rises reflecting retention and operational maturity. Egan joined in 2023 as the first CGO; Marcot brings 15+ years in health systems. These moves support scaling post-funding.
Managed Care Push Ahead
With the new funding, Anomaly plans to extend Smart Response into managed care and payer negotiations. Deployed in 20+ systems, it has already recovered tens of millions in revenue. Customers like Bronson Healthcare praise the partnership for closing the payer intelligence gap.